🥸Kidney stones that require metabolic evaluation of patient

academic.oup.com/pmj/article/...

🧬Complement Pathways and Regulators in Kidney Ds

doi.org/10.1093/ndt/...

@hjanders.bsky.social

😩Gout Management in CKD

www.ajkd.org/article/S027...

@ajkd.bsky.social

Claim your travel grant for #ISNCON25 ‼️
Submit your abstract here: isn-india.org/isn_registra...
@jasminenephro.bsky.social
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@arvindcanchi.bsky.social

🫘Non invasive biomarkers of Rejection

pubmed.ncbi.nlm.nih.gov/39419272/

@ajkd.bsky.social

🫘Renal Amyloidosis

academic.oup.com/ndt/article-...

@hjanders.bsky.social

💊🫘Drugs to prevent CKD Progression

doi.org/10.1093/ndt/...

@hjanders.bsky.social

🌟Beyond Testing—IgAN Trials Unveiled!-Must Read🌟

From #Sparsentan to #Iptacopan, innovative non-immunomodulatory & immunomodulatory therapies are transforming IgAN care!🎯

🔬 Excellent Trial insights by @Melgreux
📖 via @KidneyKolumns Jan25

#Nephrology #IgAN #ClinicalTrials

🫘🎯Light chain Amyloidosis

😬Kidneys 🫘 and heart most commonly involved

🎯Mostly nephrotic range proteinuria

@nejm.org

www.nejm.org/doi/full/10....

When should the nephrologist think about genetics in patients with glomerular diseases? Abstract. This review discusses the significance of genetics in diagnosing glomerular diseases. Advances in genetic testing, particularly next-generation s

When should the nephrologist think about genetics in patients with glomerular diseases?

doi.org/10.1093/ckj/...

👍New Lupus Nephritis guidelines

#ACR2024

🤘Major change-Triple therapy for induction ✅

🦠🫘Approach to BKV in kidney transplant recipients

doi.org/10.1093/ndt/...

@hjanders.bsky.social

SGLT2i/MRA/GLP1 agonist are our new DMANDs 🤩

🤔🤔Ever heard of DMANDs-Disease modifying anti nephropathic drugs

doi.org/10.1093/ndt/...

@hjanders.bsky.social #Nephsky
#Nephpearls

🤩 Looking great in Saree

Episode 73: The KDIGO CKD 2024 Guideline Draft — NephJC It is time for another NephJC Draft! This time the 2024 KDIGO CKD guideline draft is on the clock!

The low statin use in CKD is a scandal

It’s a 1A in the guideline but hardly noticed by most - so made it my draft pick www.nephjc.com/freelyfilter... on @freelyfiltered.bsky.social

#Statins4All
#NephSky

🫘Hyperuricemia management in CKD

❌DO NOT use urate lowering drugs in CKD with asymptomatic Hyperuricemia

@nephjc.bsky.social @kdigo.org
#NephPearls #NephSky

🫘Approach to high flow hemodialysis vascular access

#NephSky #Nephpearls

doi.org/10.23876/j.k...

KDIGO: Every CKD patient should be on a statin
KDIGO ADPKD Guidelines

🤗🫘Great insights, inspiring discussions and amazing connections at ISN WCN

@theisn.org @isn-india.bsky.social #ISNWCN

🫘When to do kidney biopsy in diabetes

academic.oup.com/ckj/advance-...

@ckj-era.bsky.social

📝Medical therapy in CKD-RAASi, SGLT2i , GLP1RA and Non steroidal MRA

doi.org/10.1093/ndt/...

@hjanders.bsky.social

Only the Bluesky is the limit: ten tips for a trending #Skytorial ABSTRACT. Threaded online medical education first emerged on X (formerly Twitter) in early 2018 following the introduction of a threading feature in Decemb

academic.oup.com/ckj/article/...

😎ADPKD bedside must know questions/pearls

@isn-india.bsky.social social media Team has launched the clinical online bedside series

🎯Sharing some pearls from the first bedside

@arvindcanchi.bsky.social @isn-india.bsky.social

🫘🧬What’s new in Acute kidney injury

Proteomics

Artificial intelligence

And more

doi.org/10.1093/ckj/...

🦠Viral Nephropathies

www.ajkd.org/article/S027...

@ajkd.bsky.social

Do not miss this exciting Bedside clinics in Nephrology series

😎

Not that rare. I would admit that I have also done this form of straightening 🤷‍♀️😊

🫘Breaking barriers and gender bias in Nephrology

Interesting read in CJASN by @kidneydoc101.bsky.social

journals.lww.com/cjasn/pages/...

💇‍♀️Brazilian hair straightening and Oxalate Nephropathy 😱

www.kidney-international.org/article/S008...